Research Library

“Nearly one billion travelers pass through U.S. airports each year,” writes Alicia L. Johnson, civic science postdoctoral associate. In a new commentary, she outlines how the CDC’s genomic surveillance program, which monitors airport wastewater for traces of infectious disease, must balance public health and privacy concerns.

The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences. Karikó’s story highlights the vital importance of supporting women in STEM.

In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.

The first step to reducing methane, Agerton and Gilbert argue, is to directly measure it. Their new Forbes post explains why inventory-based incentives that merely estimate emissions must give way to direct methane monitoring.

Texans served by regulated electricity markets, especially by electric cooperatives, were much more satisfied with their providers’ performance during Winter Storm Uri than those in deregulated markets. In this post for the Baker Institute Blog, the authors offer possible explanations for the contrast in favorability.

Despite the demand for policies that mitigate the impact of severe weather, a majority of Texans seem opposed to one that requires consumers to pay for reserve electrical generation capacity.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.

According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.

According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.